Spots Global Cancer Trial Database for altered energy metabolism directed compound
Every month we try and update this database with for altered energy metabolism directed compound cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients | NCT00907166 | Cancer Pancreatic Canc... Pancreatic Carc... | CPI-613 CPI-613 Gemcitabine Gemcitabine Gemcitabine | 18 Years - 70 Years | Cornerstone Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
